» Articles » PMID: 33213474

Validation of Novel Patient-centred Juvenile Idiopathic Arthritis-specific Patient-reported Outcome and Experience Measures (PROMs/PREMs)

Overview
Publisher Biomed Central
Specialty Pediatrics
Date 2020 Nov 20
PMID 33213474
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Measuring the outcomes that matter to children and young people (CYP) with juvenile idiopathic arthritis (JIA), is a necessary precursor to patient-centred improvements in quality of clinical care. We present a two-centre validation of novel JIA patient-reported outcome and experience measures (PROM and PREM) developed as part of the CAPTURE-JIA project.

Methods: CYP with JIA were recruited from paediatric rheumatology clinics, completing the CAPTURE-JIA PROM and PREM, CHAQ and CHU 9D. A subset participated in face-to-face interviews and completed the PROM/PREM 1 week later. The OMERACT filter was applied and the three domains of validation assessed. Truth assessments included cognitive interviewing, sensitivity analysis and Spearman's correlations. Discrimination assessments included specificity and reliability testing. Feasibility was assessed using time to form completion and proportion of missing data.

Results: Eighty-two CYP and their families were recruited; ten cognitive interviews and fifteen PROM/PREM test/retests were conducted. Truth: CYP and parents understood the PROM/PREM and felt important areas were covered. PROM criteria had high sensitivities (> 70%) against similar items on the CHU 9D, with the exception of fatigue (58%). Correlations between similar PROM and CHU 9D criteria were moderate to very strong (coefficients 0.40-0.82.) Discrimination: high specificities (> 70%) on corresponding PROM and CHU 9D domains. Feasibility: median completion times for PROM 60 s (IQR 38-75) and PREM 49 s (IQR 30-60) respectively.

Conclusion: The CAPTURE-JIA PROM and PREM are valid and feasible in UK paediatric rheumatology clinics. Embedding routine collection into clinical care would be a major step towards improving quality of care.

Citing Articles

Cultural Adaptation of Patient-Reported Indicator Surveys (PaRIS) Patient and Primary Care Practice Questionnaires to the Slovenian Context.

Ambroz M, Ropret N, Vracko P, Murko E, Kendir C, Bosnjak L Zdr Varst. 2025; 64(2):93-102.

PMID: 40026374 PMC: 11870316. DOI: 10.2478/sjph-2025-0012.


Australian adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-RA-Patient Reported Experience Measure (CQRA-RA-PREM).

Bryant M, Black R, Lester S, Chand V, Barrett C, Buchbinder R Rheumatol Adv Pract. 2024; 8(4):rkae099.

PMID: 39376963 PMC: 11457261. DOI: 10.1093/rap/rkae099.


Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up.

Spekking K, Anink J, de Boer P, Bergstra S, van den Berg J, Schonenberg-Meinema D Pediatr Rheumatol Online J. 2023; 21(1):90.

PMID: 37633893 PMC: 10464062. DOI: 10.1186/s12969-023-00874-z.


Hospital healthcare experiences of children and young people with life-threatening or life-shortening conditions, and their parents: scoping reviews and resultant conceptual frameworks.

Mukherjee S, Richardson N, Beresford B BMC Pediatr. 2023; 23(1):366.

PMID: 37460965 PMC: 10351142. DOI: 10.1186/s12887-023-04151-6.


Patient-reported outcome measures can advance population health, but is access to instruments and use equitable?.

McCabe C, Wood G, Franceschelli-Hosterman J, Cochran W, Savage J, Bailey-Davis L Front Pediatr. 2022; 10:892947.

PMID: 36330368 PMC: 9622997. DOI: 10.3389/fped.2022.892947.


References
1.
Boers M, Beaton D, Shea B, Maxwell L, Bartlett S, Bingham 3rd C . OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. J Rheumatol. 2019; 46(8):1021-1027. DOI: 10.3899/jrheum.181096. View

2.
Muller-Godeffroy E, Lehmann H, Kuster R, Thyen U . [Quality of life and psychosocial adaptation in children and adolescents with juvenile idiopathic arthritis and reactive arthritis]. Z Rheumatol. 2005; 64(3):177-87. DOI: 10.1007/s00393-005-0652-5. View

3.
McErlane F, Beresford M, Baildam E, Thomson W, Hyrich K . Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. Rheumatology (Oxford). 2013; 52(11):1941-51. DOI: 10.1093/rheumatology/ket150. View

4.
Symmons D, Jones M, Osborne J, Sills J, Southwood T, Woo P . Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol. 1996; 23(11):1975-80. View

5.
Shoop-Worrall S, Verstappen S, McDonagh J, Baildam E, Chieng A, Davidson J . Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition. Arthritis Rheumatol. 2018; 70(9):1519-1529. PMC: 6175118. DOI: 10.1002/art.40519. View